OncoSystem Directory
Explore organizations in the global Oncology ecosystem
724 organization(s) found
Orum Therapeutics
Orum Therapeutics, Inc. is a biopharmaceutical company leveraging our proprietary platforms for research and development of new pharmaceuticals for cancer and immune diseases. We are pioneering a class of therapeutics intended to expand the universe of druggable targets and to meaningfully improve upon potency and tolerability, and thereby improve the therapeutic window of drugs. Our goal is to bring life-changing therapies to patients by combining the power of the emerging field of protein degraders with the precision of antibodies to generate a broad portfolio of highly differentiated product candidates.
Targeted protein-degradation conjugates (TPD2) for Oncology
Yuseong-Gu, Daejeon, South Korea
WebsiteOutpace Bio
Outpace Bio is building a robust pipeline of engineered T cell therapies with curative potential that leverage Outpace technologies across modalities, targets, and indications.
T-cell therapies (CAR-T, TCR-T) for Oncology Seattle, WA, United States WebsiteOxford BioTherapeutics
Oxford BioTherapeutics is a clinical-stage oncology company, developing first-in-class antibody-based therapies to improve patient outcomes. Our proprietary, proteomic target discovery platform, OGAP�-Verify, specialises in identifying novel membrane-based protein targets.
ADCs and TCEs for treatment of solid tumors Oxford, United Kingdom WebsitePACRI (Pan African Cancer Research Institute)
The Pan African Cancer Research Institute (PACRI) is a centre of excellence dedicated to cutting edge integrated translational cancer research, education and clinical care with a vision of accelerating discoveries to prevent and cure cancer in the African region. It is aimed at developing internationally competitive cancer research capabilities in Africa with an emphasis on Afrocentric solutions, enhancing the probability of finding homegrown solutions for the cancer challenges faced by the continent. The Institute is about research and healthcare for all Africans by Africans. PACRI is distinguished by meeting rigorous standards for transdisciplinary, state-of-the-art research focused on developing new and better approaches to preventing, diagnosing, and treating cancer and advancing precision/personalised oncology in the region. In the spirit of “Defeating Cancer Together”, PACRI has a strong drive in collaborative transdisciplinary research that addresses cancer health disparities and its impact on underserved and socio-economically disadvantaged populations.
Translational Oncology Research Pretoria, South Africa WebsitePamDx
At PamDx we are dedicated to support physicians and scientists in finding solutions and answers to improve and optimize patient treatment and understand diseases. Our multiplex kinase activity profiling technology reveals the bigger picture of cellular signaling and provides mechanistic insights needed to fully understand diseases and cell alterations.
Kinase activity profiling for Oncology R&D and diagnostics Hertogenbosch, Netherlands WebsitePersea Pharma
Persea is developping BioTrojan, a cellular Trojan Horse delivered locally for a powerfull local impact.
Targeted gene therapy for treatment of solid tumors Suresnes, France WebsitePeter MacCallum Cancer Centre
Peter Mac is a Comprehensive Cancer Centre, delivering integrated treatment, research and education and leading the way in cancer care across Australia
Cancer Care & Research Melbourne, VIC, Australia WebsitePETHEMA (Programa Español de Tratamientos en Hematología)
In Spanish: "PETHEMA es un grupo cooperativo de médicos especialistas y otros profesionales sanitarios de diversa índole que trabajan coordinadamente para el desarrollo de investigación de la máxima calidad científica en Medicina, concretamente en el campo de la Hematología (especialidad que se centra en el estudio de la sangre, la médula ósea y los órganos linfáticos). PETHEMA, cuyas siglas responden a “Programa Español de Tratamientos en Hematología”, es un grupo de investigación de naturaleza académica e independiente, que pertenece a la Sociedad Española de Hematología y Hemoterapia (SEHH). La SEHH que es la sociedad científica que aglutina la defensa central e integrada de todos los intereses relacionados con la especialidad de Hematología y Hemoterapia y que busca por encima de todo el máximo nivel de excelencia en el ejercicio de la medicina hematológica."
Hematology Madrid, Spain WebsitePGIMER - Postgraduate Institute of Medical Education and Research
Chandigarh, India WebsitePheon Therapeutics
Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat difficult-to-treat solid tumors.
WebsitePhillips Healthcare
At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. As a technology company, we – and our brand licensees – innovate for people with one consistent belief: there’s always a way to make life better.
Medical Imaging, Medical Devices, Medical Equipment, Healthcare IT Services Amsterdam, Netherlands WebsitePierre Fabre
We take care of life by designing and developing innovative solutions inspired by consumers and patients and contributing to the well-being of everyone from health to beauty. We achieve this by cooperating with health-care professionals, our trusted partners worldwide, by drawing relentless inspiration from nature and plants, and by placing pharmaceutical ethics at the very heart of our operations.
Oncology, Dermatology, Onco-dermatology, OTC, Cosmetics Castres, France WebsitePinkDrive – South Africa
Organisation focusing on cancer (especially women’s cancers) awareness, screening and early detection campaigns in South Africa. (From list of cancer NGOs in South Africa.)(canceralliance.org.za)
Randburg, South Africa WebsitePinot Bio
Pinotbio is a biotech company developing new treatments for patients resistant to existing therapies based on innovative new drug modalities such as antibody-drug conjugates (ADCs). Based on our strong R&D capabilities, we have built our next-generation ADC platform, PINOT-ADC� independently and have been working with various partners to research new ADC anticancer treatments.
ADCs and small-molecules for Oncology Yeongtong-gu, Suwon-si,
Gyeonggi-do, South Korea WebsitePMV Pharmaceuticals
At PMV, we believe that by specifically targeting each mutant p53 we can fundamentally disrupt the course of cancer. Our research and development efforts are dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.
Small-molecule drugs targeting mutated p53 and other targets in Oncology Princeton, NJ, United States Website